Skip to main content
Caplight Logo









CH-Bioforce Oy

CH-Bioforce Oy

Private
EspooEnergy & Sustainabilityhttps://www.ch-bioforce.com/

Last Round

Grant

Jun 22, 2022

Total Funding Raised

$2.52M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CH-Bioforce Oy is a cleantech company that has developed a biomass fractionation technology to convert waste streams into complete bio-based materials like cellulose, lignin, and hemicellulose.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Advanced Materials, Circular Economy, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biomass fractionationbiomaterialssustainable materialsdissolving cellulosesulfur-free ligninhemicellulosetechnology licensingbiorefineryfossil-free materialscleantechwaste valorizationcircular economyindustrial biotechagricultural waste processingbio-based chemicalsbio-based textilesbio-based cosmetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CH-Bioforce Oy Comparables

Compare CH-Bioforce Oy with similar companies based on industry and business-model similarity.

CH-Bioforce Oy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lixea
90%
Bloom Biorenewables
84%
CELLiCON
84%

CH-Bioforce Oy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 22, 2022
AcceleratorFeb 27, 2020
GrantMar 1, 2019

Key People

Founding team and executive leadership

Petri Tolonen

Chief Executive Officer

Executive Team

Tapani Niskanen

CEO

Executive Team

Nicholas Lax

Chief Technology Officer

Executive Team

CH-Bioforce Oy Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 43% MoM.

  • Apr 18, 2026

    Monthly visitors increased 40% MoM.

Recent news

Latest coverage and updates

  • attends_eventJun 26, 2026

    CH-Bioforce Oy was planning to attend event GITEX AI Europe 2026 on Jun 30th '26.

  • is_developingJun 25, 2026

    CH-Bioforce Oy is developing bio-based solutions for microbial control.

CH-Bioforce Oy Filings

Explore SEC and related filing metadata, where available.

CH-Bioforce Oy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CH-Bioforce Oy's valuation, stock price, and market status.

Is CH-Bioforce Oy a public or private company?

CH-Bioforce Oy is a private company.

What is the current stock price of CH-Bioforce Oy?

CH-Bioforce Oy is a private company with no public stock price. No recent secondary market data is available.

How much is CH-Bioforce Oy worth (valuation)?

Valuation information for CH-Bioforce Oy is not publicly available.

Can I buy CH-Bioforce Oy stock?

CH-Bioforce Oy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CH-Bioforce Oy's last funding round?

CH-Bioforce Oy's most recent funding round was Grant on June 22, 2022.

Who are the main investors in CH-Bioforce Oy?

Key investors in CH-Bioforce Oy include European Innovation Council, 100+ Accelerator.

Will CH-Bioforce Oy IPO soon?

No public IPO plans have been announced for CH-Bioforce Oy.

How can I track CH-Bioforce Oy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CH-Bioforce Oy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEspoo
Employee Range5
Year Founded2016
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?